United Therapeutics UTHR
NASDAQ UTHR
$542.03 +60.56 (+12.58%)
As of: Sep 30, 2026 · 3:59 PM EDT

United Therapeutics (UTHR) Revenue (2009 - 2026)

Updated

United Therapeutics (UTHR) recorded Revenue of $783.3 million in Q2 2026, down 1.9% from $798.6 million a year earlier but up 0.2% from the prior quarter.

Analysis

United Therapeutics (UTHR) Revenue (2009 - 2026) Analysis & Trends

On a TTM basis, United Therapeutics' Revenue came in at $3.15 billion as of Jun 30, 2026, up 2.5% year-over-year; for FY2025, it came in at $3.18 billion, up 10.6% from FY2024.

  • Annual Revenue has increased for six straight years, with a five-year compound annual growth rate of 16.5% (FY2020 to FY2025).
  • Across earlier years, Revenue came in at $2.88 billion in FY2024 (+23.6%), $2.33 billion in FY2023 (+20.2%), $1.94 billion in FY2022 (+14.9%) and $1.69 billion in FY2021 (+13.6%).
  • Quarterly Revenue has ranged from $415.2 million in Q4 2021 to $799.5 million in Q3 2025 over the past five years.
  • On a year-over-year basis, Revenue rose in six of the last eight quarters, with growth averaging 10.3%.
  • Peak year-over-year performance for Revenue in the last five years was growth of 33.7% in Q1 2024, against a decline of 1.9% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $781.5 million (Q1 2026), $790.2 million (Q4 2025) and $799.5 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 25.31 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 16.99 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 15.38 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 3.33 Bn
10 United Therapeutics 20.55 Bn 10.04 Bn 683.80 Mn 783.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 783.30 Mn
Mar 31, 2026 781.50 Mn
Dec 31, 2025 790.20 Mn
Sep 30, 2025 799.50 Mn
Jun 30, 2025 798.60 Mn
Mar 31, 2025 794.40 Mn
Dec 31, 2024 735.90 Mn
Sep 30, 2024 748.90 Mn
Jun 30, 2024 714.90 Mn
Mar 31, 2024 677.70 Mn
Dec 31, 2023 614.70 Mn
Sep 30, 2023 609.40 Mn
Jun 30, 2023 596.50 Mn
Mar 31, 2023 506.90 Mn
Dec 31, 2022 491.50 Mn
Sep 30, 2022 516.00 Mn
Jun 30, 2022 466.90 Mn
Mar 31, 2022 461.90 Mn
Dec 31, 2021 415.20 Mn
Sep 30, 2021 444.70 Mn
API Access

United Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=UTHR&period=max&api_key=YOUR_API_KEY